26.9 C
Karachi
Tuesday, October 8, 2024
HomeTagsGSK

Tag: GSK

GSK, Novartis pledge funds for diseases that mostly affect the poor

GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways...

Unilever’s offer for GSK’s consumer health raises doubts

Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected -- should it raise the...

US secures 600,000 more doses of COVID-19 therapy Sotrovimab

The United States has agreed to buy 600,000 more doses of GSK and Vir Biotechnology's COVID-19 antibody therapy for an undisclosed sum, as the...

New data shows GSK-Vir drug works against all Omicron mutations

British drugmaker GSK said on Tuesday its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron...

GSK, CureVac’s next-gen COVID-19 vaccine shows promise

GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine candidate to be "strongly improved" in protecting against the...

GSK drug shows promise as treatment in kidney disease patients

GSK said on Friday its anaemia drug for patients with kidney disease succeeded in late-stage trials, marking an important milestone for the British drugmaker...

Sanofi, GSK get Indian approval for trial of COVID-19 vaccine

Sanofi and GlaxoSmithKline have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said...

Sanofi, GSK launch final phase of Covid vaccine trials

The companies reported positive results from interim human trials earlier this month after a disappointing outcome from initial studies last year left France without its own vaccine

GSK buys 10% of CureVac in vaccine tech deal

GSK and CureVac, backed by Microsoft billionaire Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases

Britain nears US$625 million Sanofi/GSK COVID-19 vaccine deal: report

Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine.

World’s largest vaccine maker reveals COVID-19 vaccine plans

There is a notable name missing from the frontrunners in the race to test experimental immunisations against the novel coronavirus: the world’s largest vaccine maker GlaxoSmithKline

GSK to produce 1 billion doses of vaccine efficacy boosters

The world’s largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for COVID-19

GSK ends development of Ebola vaccine

While Ebola is a deadly and contagious disease, it is also still relatively rare, making the potential market for a vaccine sporadic and very likely unprofitable

HIV drug wins European panel thumbs-up

GlaxoSmithKline’s two-drug treatment for HIV infections won marketing approval from a European Medicines Agency (EMA)

GSK, Pfizer to merge consumer healthcare units

LONDON: Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines. GSK said it would have...

GSK ‘real world’ drug test has second success in asthma

LONDON: GlaxoSmithKline notched up a second win for its pioneering "real world" approach to testing new drugs on Friday as its inhaled medicine Breo...

Gilead challenges GSK with strong HIV drug data

SEATTLE: Gilead Sciences has thrown down a challenge to GlaxoSmithKline with good clinical trial results for an experimental HIV drug that works in the...

GSK cuts vaccine price for refugees, bowing to pressure

LONDON: GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's "exorbitant" cost by medical charity Medecins Sans Frontieres.

‘Work on Ebola vaccine moving fast’

LONDON: Britain's biggest drugmaker GlaxoSmithKline said on Saturday work to develop a vaccine to combat Ebola, which has killed thousands in West Africa, was moving at a rapid pace.

Clinical trial to start soon on Ebola vaccine

LONDON: A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.

BREAKING NEWS

MUST READ

ABOUT US

ARY NEWS brings you 24/7 Live Streaming, Headlines, Bulletins, Talk Shows, Infotainment, and much more. Watch minute-by-minute updates of current affairs and happenings from Pakistan and all around the world!

CORPORATE

ARY NETWORK

DOWNLOAD NOW!

© 2023 ARYNEWS.tv. All Rights Reserved.